Skip to main content
    E

    Evogene (EVGN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.39
    +0.02 (+5.58%)

    Market Cap: $6.70M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    41%(15/37)
    Avg Surprise
    -19.85%
    Streak
    1 Q

    Upcoming Estimates

    Reports Nov 19, 2026 before openPeriod ending Sep 30, 2026
    EPS Consensus-$0.19
    Range-$0.19 - -$0.19
    1 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.27+29.6%
    60d ago-$0.27+29.6%
    30d ago-$0.27+29.6%
    7d ago-$0.27+29.6%
    Current-$0.19
    Revenue Consensus
    $365.00K
    Range$365.00K - $365.00K
    1 analysts
    Reports Mar 3, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.20
    RangeN/A
    3 analysts
    Revenue Consensus
    $397.80K
    Range$382.20K - $409.50K
    3 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-0.41xFCF Yield-242.00%
    Profitability
    Profit Margin0.00%Operating Margin-858.00%
    ROE-182.70%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage-2.77x
    Current Ratio3.57xQuick Ratio3.54x
    Trading Statistics
    Beta0.67Avg Volume551.70K
    52-Week High$1.2652-Week Low$0.25

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 3.6% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 53.1, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$0.35
    SMA 20$0.36
    SMA 50$0.41
    SMA 200$0.63
    EMA 10$0.36
    EMA 20$0.37
    EMA 50$0.41
    EMA 200$0.62

    MACD

    Line: -0.01Signal: -0.02Hist: 0.01

    ADX

    ADX: 22.0+DI: 33.0-DI: 16.0

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down76.0
    PSAR$0.27

    Bollinger Bands

    Upper Band$0.42
    Lower Band$0.30
    %B Position3428%(Upper)
    Band Width0.76

    RSI (14-Day)

    Neutral
    53.1

    Momentum Oscillators

    Stoch %K67.7
    Stoch %D69.9
    Williams %R-25.6
    ROC (10d)8.5%
    Momentum0.03
    CCI (20d)130.3
    MFI (14d)30.0

    Volatility Measures

    ATR (14d)$0.05(12.0%)
    StdDev (20d)0.03
    Hist Vol139.5%(High)

    Volume Flow

    VWAP$0.40
    OBV128.6M
    AD Line53.5M
    CMF (20d)0.310

    Volume Metrics

    Avg Vol (20d)573.4K
    Vol Ratio0.3x(Low)
    VWMA (20d)$0.34

    Pivot Points

    R3$0.42
    R2$0.40
    R1$0.39
    Pivot Point$0.37
    S1$0.36
    S2$0.34
    S3$0.33

    Advanced Oscillators

    TSI-9.41
    Ultimate Osc49.3
    KST-132.26

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about EVGN

    News

    EVGN Valuation

    GNG's valuation label for EVGN is Fairly valued.

    P/FCF
    -0.4x
    P/B
    -1.5x
    All EVGN metrics

    EVGN Profitability: Margins, ROIC and FCF

    Evogene (EVGN) has a gross margin of -123.9%, an operating margin of -858.0% and a net margin of 0.0%. It posts a -884.8% FCF margin.

    Gross margin
    -123.9%
    Operating margin
    -858.0%
    Net margin
    0.0%
    ROE
    -182.7%
    FCF margin
    -884.8%
    FCF yield
    -242.0%
    EVGN financial statements

    The companies most similar to Evogene (EVGN) include Soligenix, GT Biopharma and In8bio.

    Sector: Healthcare

    Companies most similar to Evogene

    EVGN Bull Case vs Bear Case

    Bear case

    • EVGN's quarterly revenue changed -60.7% year over year.

    EVGN Earnings: Beat Rate and Next Report

    Evogene (EVGN) beat the EPS estimate in 4 of the last 8 quarters (50.0%). Its next report is confirmed on Nov 19, 2026.

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -1.7%
    EPS estimate (fiscal period ending Sep 30, 2026)
    -$0.19
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 0 down
    EVGN earnings history

    EVGN Earnings Date

    EVGN reports Nov 19, 2026, before the open. The date is confirmed.

    EVGN Earnings Call

    The latest EVGN earnings call transcript on file is labeled 2026Q2.

    Read the 2026Q2 transcript

    Updated Aug 23, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About EVGN

    When does EVGN report earnings?

    Evogene (EVGN) is confirmed to report earnings on Nov 19, 2026.

    Does EVGN pay dividends?

    Evogene (EVGN) does not currently pay a regular dividend.

    What is EVGN's market cap?

    Evogene (EVGN) has a market capitalization of $6.70M with a current stock price of $0.39.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.